Maureen Deehan
Amministratore Delegato presso Vivtex Corp.
Posizioni attive di Maureen Deehan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Vivtex Corp. | Amministratore Delegato | 21/02/2023 | - |
| Direttore operativo | 01/12/2022 | 21/02/2023 |
Storia della carriera di Maureen Deehan
Precedenti posizioni note di Maureen Deehan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| THOR MEDICAL | Corporate Officer/Principal | 01/06/2018 | - |
Formazione di Maureen Deehan
| University of Glasgow School of Medicine | Doctorate Degree |
| University of Strathclyde | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
| Norvegia | 2 |
| Stati Uniti | 2 |
Posizioni
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
| Vivtex Corp. |
- Borsa valori
- Insiders
- Maureen Deehan
- Esperienza
